MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0070070
Starior Pharma Private Limited
Starior Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.94 Cr
▲ 9% YoY
Net profit · FY 2025
₹18.31 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹35.96 Lakh
EBITDA margin 7.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹75 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Starior Pharma Private Limited
Data last updated:
Starior Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC129405. Its GSTIN is 36ABBCS3515M1Z7 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Starior Life Sciences Private Limited. It is led by directors Vijay Kumar Vembakam and Sandhya Vembakkam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No. 4 – 4 – 42/96/1 2nd Floor Koundinya Nagar Nacharam, Hyderabad, Telangana, India – 500076.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.94 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹18.31 Lakh (net margin 3.7%) and EBITDA of ₹35.96 Lakh (EBITDA margin 7.3%). Revenue has grown at a compounded annual rate (CAGR) of 135% over three years and 65% over five years.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
Starior Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0070070).
Company details
CIN U24239TG2019PTC129405
Registration Number 129405
Incorporation Date 01 January 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0070070
Recognitions & Rankings of Starior Pharma
Contact details
Starior Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressDoor No. 4 – 4 – 42/96/1 2nd Floor Koundinya Nagar Nacharam, Hyderabad, Telangana, India – 500076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Starior Pharma Private Limited, buy the company report.
Comprehensive company report
Starior Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Starior Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Starior Pharma Private Limited, buy the company report.
Financials of Starior Pharma Private Limited
FY 2025 filings availableStarior Pharma Private Limited reported revenue of ₹4.94 Cr (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹4.94 Cr ▲ 9%
Net profit · FY 2025
₹18.31 Lakh margin 3.7%
EBITDA · FY 2025
₹35.96 Lakh margin 7.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 135%
5 years · compounded
▲ 65%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 56%
5 years · compounded
▲ 55%
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years, including 9% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹35.96 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Starior Pharma Private Limited, buy the company report.
Board of directors of Starior Pharma Private Limited
Starior Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Kumar Vembakam | Director | 01 Jan 2019 | 7 Years 9 Months | Current |
| Sandhya Vembakkam | Director | 30 Jul 2022 | 4 Years 2 Months | Current |
Peer comparison
Starior Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adips Laboratories Limited | ₹4.97 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Sanral Pharma Private Limited | ₹4.97 Cr (FY 2024) | 23.0% | Jodhpur, Rajasthan, India | |||
| Anevay Pharmaceuticals Private Limited | ₹4.94 Cr (FY 2025) | 9.0% | Chandigarh, India | |||
| Starior Pharma Private Limitedthis company | ₹4.94 Cr (FY 2025) | ₹18.31 Lakh | 3.7% | 9.0% | Hyderabad, Telangana, India | |
| Woodavens Pharmacare Private Limited | ₹4.92 Cr (FY 2025) | 24.0% | Bilaspur, Chhattisgarh, India | |||
| Matrix Labs Private Limited | ₹4.91 Cr (FY 2024) | 103.0% | Chennai, Tamil Nadu, India | |||
| Virtuarc Private Limited | ₹4.91 Cr (FY 2023) | 41.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Starior Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹75 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 May 2025 | 101099530 | State Bank of India | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Starior Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Starior Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Starior Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABBCS3515M1Z7 | Telangana | Active | 18 Jan 2019 |
To see the full GST registrations and return filing status of Starior Pharma Private Limited, buy the company report.
Recent activity
Starior Pharma Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Sandhya Vembakkam ceased to be Additional Director on 29 Sep 2024.
AGM
Starior Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 75.00 Lakh with Charge ID 101099530 was registered on 13 May 2025.
Filing
Starior Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Sandhya Vembakkam ceased to be Additional Director.
Ceased
Surendranath Vempakkam Ravikumar ceased to be Director.
Appointed
Sandhya Vembakkam was appointed as Director.
Ceased
Narsimha Reddy Nalla ceased to be Director.
Appointed
Vijay Kumar Vembakam was appointed as Director.
Incorporation
01 Jan 2019
Starior Pharma Private Limited was registered on 01 Jan 2019 with Roc Hyderabad & aged 7 years 9 months as per MCA records.
Frequently asked questions
Starior Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 January 2019 (7+ years old) and is registered under CIN U24239TG2019PTC129405.
Starior Pharma has 2 current directors:
- Vijay Kumar Vembakam - Director
- Sandhya Vembakkam - Director
The latest financial statements of Starior Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Starior Pharma is 36ABBCS3515M1Z7, registered in Telangana.
The CIN (Corporate Identification Number) of Starior Pharma is U24239TG2019PTC129405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Starior Pharma was incorporated on 01 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Starior Pharma by revenue are Adips Laboratories Limited, Sanral Pharma Private Limited, Anevay Pharmaceuticals Private Limited, Woodavens Pharmacare Private Limited, Matrix Labs Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sandhya Vembakkam ceased to be Additional Director on 29 Sep 2024. Surendranath Vempakkam Ravikumar ceased to be Director on 11 Aug 2022. Sandhya Vembakkam was appointed as Director on 30 Jul 2022. Starior Pharma has 5 board changes on record in total.
Yes, Starior Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0070070).
The registered office of Starior Pharma is at Door No. 4 – 4 – 42961 2nd Floor Koundinya Nagar Nacharam, Hyderabad, Telangana, India – 500076.
Starior Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.